Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salomaa

Showing results (721-730 of 991) with videos related to

Pageof 100
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2017
Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease: Meta-Analysis of Six Population-Based CohortsChristian Herder, Tonia de Las Heras Gala, Maren Carstensen-Kirberg, et al.
Plos One|August 1, 2012
Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohortsMaria F Hughes, Olli Saarela, Jan Stritzke, et al.
Circulation|October 18, 2017
Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)Christina Magnussen, Teemu J Niiranen, Francisco M Ojeda, et al.
Genome Biology|August 3, 2017
An interaction map of circulating metabolites, immune gene networks, and their genetic regulationArtika P Nath, Scott C Ritchie, Sean G Byars, et al.
Journal of the American College of Cardiology|March 12, 2016
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA ReductasePeter Würtz, Qin Wang, Pasi Soininen, et al.
European Heart Journal|April 28, 2017
Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortiumChristoph Waldeyer, Nataliya Makarova, Tanja Zeller, et al.
European Heart Journal|January 13, 2021
Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomesDora Csengeri, Ngoc-Anh Sprünker, Augusto Di Castelnuovo, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Microbiome-based risk prediction in incident heart failure: a community challengePande Putu Erawijantari, Ece Kartal, José Liñares-Blanco, et al.
Nature Communications|January 26, 2019
Contribution of rare and common variants to intellectual disability in a sub-isolate of Northern FinlandMitja I Kurki, Elmo Saarentaus, Olli Pietiläinen, et al.
Journal of the American Heart Association|May 1, 2020
Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and DeathBenedikt Schrage, Bastiaan Geelhoed, Teemu J Niiranen, et al.
Pageof 100

Showing results (721-730 of 991) with videos related to

Sort By:
Pageof 100
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2017
Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease: Meta-Analysis of Six Population-Based CohortsChristian Herder, Tonia de Las Heras Gala, Maren Carstensen-Kirberg, et al.
Plos One|August 1, 2012
Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohortsMaria F Hughes, Olli Saarela, Jan Stritzke, et al.
Circulation|October 18, 2017
Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)Christina Magnussen, Teemu J Niiranen, Francisco M Ojeda, et al.
Genome Biology|August 3, 2017
An interaction map of circulating metabolites, immune gene networks, and their genetic regulationArtika P Nath, Scott C Ritchie, Sean G Byars, et al.
Journal of the American College of Cardiology|March 12, 2016
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA ReductasePeter Würtz, Qin Wang, Pasi Soininen, et al.
European Heart Journal|April 28, 2017
Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortiumChristoph Waldeyer, Nataliya Makarova, Tanja Zeller, et al.
European Heart Journal|January 13, 2021
Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomesDora Csengeri, Ngoc-Anh Sprünker, Augusto Di Castelnuovo, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Microbiome-based risk prediction in incident heart failure: a community challengePande Putu Erawijantari, Ece Kartal, José Liñares-Blanco, et al.
Nature Communications|January 26, 2019
Contribution of rare and common variants to intellectual disability in a sub-isolate of Northern FinlandMitja I Kurki, Elmo Saarentaus, Olli Pietiläinen, et al.
Journal of the American Heart Association|May 1, 2020
Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and DeathBenedikt Schrage, Bastiaan Geelhoed, Teemu J Niiranen, et al.
Pageof 100